BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11959219)

  • 1. Dyslipemia and long-term immunosuppression.
    Charco R
    Transplant Proc; 2002 Feb; 34(1):124-6. PubMed ID: 11959219
    [No Abstract]   [Full Text] [Related]  

  • 2. The spectrum of complications of immunosuppression: is the time right for hand transplantation?
    Brenner MJ; Tung TH; Jensen JN; Mackinnon SE
    J Bone Joint Surg Am; 2002 Oct; 84(10):1861-70. PubMed ID: 12377920
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperlipidemia and cardiovascular disease after organ transplantation.
    Massy ZA
    Transplantation; 2001 Sep; 72(6 Suppl):S13-5. PubMed ID: 11585238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.
    Legendre C; Viebahn R; Fehrman-Ekholm I; Masnou N; Berenguer M; Potena L; Wennberg L; O'Grady J; Epailly E; Diekmann F; Binet I; Schwenger V; Kuypers D; Guthoff M
    Transplantation; 2018 Sep; 102(9S Suppl 1):S1-S14. PubMed ID: 30113932
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-transplant hyperlipidemia: mechanisms and management.
    Massy ZA; Kasiske BL
    J Am Soc Nephrol; 1996 Jul; 7(7):971-7. PubMed ID: 8829110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting single-kidney allografts from long-term functional deterioration.
    Remuzzi G; Perico N
    J Am Soc Nephrol; 1998 Jul; 9(7):1321-32. PubMed ID: 9644646
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.
    Rabkin JM; Rosen HR; Corless CL; Olyaei AJ
    Transplant Proc; 2002 Aug; 34(5):1557-8. PubMed ID: 12176483
    [No Abstract]   [Full Text] [Related]  

  • 8. Coping with rejection: immunosuppressants and organ transplantation.
    Woodcock J
    Drug Discov Today; 2005 Jan; 10(1):11-3. PubMed ID: 15676293
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population.
    First MR
    Transplantation; 2001 Sep; 72(6 Suppl):S20-4. PubMed ID: 11585240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
    Smedman TM; Line PD; Guren TK; Dueland S
    Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-transplant hyperlipidaemia.
    Jindal RM
    Postgrad Med J; 1997 Dec; 73(866):785-93. PubMed ID: 9497947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new in childhood organ transplantation.
    Sudan D; Bacha EA; John E; Bartholomew A
    Pediatr Rev; 2007 Dec; 28(12):439-53. PubMed ID: 18055642
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of the kidney transplant recipient.
    Padiyar A; Akoum FH; Hricik DE
    Prim Care; 2008 Sep; 35(3):433-50, v. PubMed ID: 18710663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation--a medical miracle of the 20th century.
    Morris PJ
    N Engl J Med; 2004 Dec; 351(26):2678-80. PubMed ID: 15616201
    [No Abstract]   [Full Text] [Related]  

  • 15. New paradigms in immunosuppression.
    Huizinga R; Voyer T
    CANNT J; 2003; 13(3):66-8. PubMed ID: 14596200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression.
    Risaliti A; Baccarani U; Vianello V; Donini A; Adani GL; Sainz M; Montanaro D; Alessandrini V; Bresadola F
    Transplant Proc; 2001; 33(7-8):3684-5. PubMed ID: 11750569
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical update: immunosuppression minimisation.
    Sayegh MH; Remuzzi G
    Lancet; 2007 May; 369(9574):1676-8. PubMed ID: 17512842
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid analysis in an aging population.
    Pallazola VA; Sathiyakumar V; Martin SS
    Aging (Albany NY); 2019 Feb; 11(4):1073-1074. PubMed ID: 30733425
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular risk factors and immunosuppressive regimen after liver transplantation.
    Rossetto A; Bitetto D; Bresadola V; Lorenzin D; Baccarani U; De Anna D; Bresadola F; Adani GL
    Transplant Proc; 2010 Sep; 42(7):2576-8. PubMed ID: 20832547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional and novel approaches to immunosuppression.
    Floreth T; Bhorade SM; Ahya VN
    Clin Chest Med; 2011 Jun; 32(2):265-77. PubMed ID: 21511089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.